misetionamide
panavance therap
['ovarian', 'pancreatic', 'gp-2250']
significant new preclinical data on gp-2250 will be presented by md anderson this sunday at the aacr annual meeting. for more information, visit: #aacr23#cancer #oncology #disruptingcancersenergy #pancreaticcancer #ovariancancer 
We are a clinical-stage pharmaceutical company focused on improving the outcomes and lives of cancer patients.